Northwest Biotherapeutics Announces Expansion of Its Technical Team
Company Expanding Key Operational Areas BETHESDA, Md., Oct. 26, 2026 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) NWBio a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has expanded its technical team in the US....